Potential use of the comet assay in the clinical management of cancer

Declan McKenna, Stephanie McKeown, Valerie J McKelvey-Martin

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.
LanguageEnglish
Pages183-190
JournalMutagenesis
Volume23
Issue number3
DOIs
Publication statusPublished - 2008

Fingerprint

Comet Assay
Assays
Neoplasms
DNA Damage
Tumors
DNA
Environmental Monitoring
Radiation Tolerance
DNA Repair
Pharmaceutical Preparations
Radiation
Oxidative stress
Oxidative Stress
Repair
Monitoring
Testing

Keywords

  • Comet Assay
  • FISH-Comet
  • DNA Damage & repair

Cite this

McKenna, Declan ; McKeown, Stephanie ; McKelvey-Martin, Valerie J. / Potential use of the comet assay in the clinical management of cancer. In: Mutagenesis. 2008 ; Vol. 23, No. 3. pp. 183-190.
@article{e9d4bdabc5fd4af5872ac69165e483fd,
title = "Potential use of the comet assay in the clinical management of cancer",
abstract = "The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.",
keywords = "Comet Assay, FISH-Comet, DNA Damage & repair",
author = "Declan McKenna and Stephanie McKeown and McKelvey-Martin, {Valerie J}",
year = "2008",
doi = "10.1093/mutage/gem054",
language = "English",
volume = "23",
pages = "183--190",
journal = "Mutagenesis",
issn = "0267-8357",
number = "3",

}

Potential use of the comet assay in the clinical management of cancer. / McKenna, Declan; McKeown, Stephanie; McKelvey-Martin, Valerie J.

In: Mutagenesis, Vol. 23, No. 3, 2008, p. 183-190.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Potential use of the comet assay in the clinical management of cancer

AU - McKenna, Declan

AU - McKeown, Stephanie

AU - McKelvey-Martin, Valerie J

PY - 2008

Y1 - 2008

N2 - The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.

AB - The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.

KW - Comet Assay

KW - FISH-Comet

KW - DNA Damage & repair

U2 - 10.1093/mutage/gem054

DO - 10.1093/mutage/gem054

M3 - Article

VL - 23

SP - 183

EP - 190

JO - Mutagenesis

T2 - Mutagenesis

JF - Mutagenesis

SN - 0267-8357

IS - 3

ER -